PFIZER REPORTS FIRST-QUARTER 2016 RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
Pfizer (PFE) Tops Q1 EPS by 12c; Boosts FY16 Outlook
May 3, 2016 6:46 AM EDTPfizer (NYSE: PFE) reported Q1 EPS of $0.67, $0.12 better than the analyst estimate of $0.55. Revenue for the quarter came in at $13 billion versus the consensus estimate of $12 billion.
GUIDANCE:
Pfizer sees FY2016 EPS of $2.38 - $2.48, versus prior guidance of $2.20 - $2.30 and... More
